DePuy’s parent company, Johnson & Johnson, has announced that it will enter into a $2.475 billion DePuy hip settlement agreement with plaintiffs in MDL 2197. The DePuy hip settlement covers patients who have undergone a revision surgery as of August 31, 2013. Individuals who have not undergone a revision as of August 31, 2013, still have legal rights available to them and should contact our firm to discuss them.
DePuy Hip Replacement Lawyer
ATTENTION: BROADSPIRE HAS BEEN HIRED TO USE YOUR MEDICAL RECORDS AGAINST YOU. REMEMBER, BROADSPIRE PROTECTS DEPUY, WE PROTECT YOU. BEFORE YOU RELEASE RECORDS SPEAK WITH ONE OF OUR ATTORNEYS
Depuy Orthopedics, a division of Johnson and Johnson, has issued a WORLDWIDE RECALL of it's "metal-on-metal" ASR XL Acetabular System for Total Hip Replacement. The hip recall came after a determination that the these Hip Implants fail at an alarming rate. These "metal-on-metal" DePuy hip replacementcan shed particles into the patient causing serious, painful reactions, often leading to further surgery.
Depuy has released the following statement to the public:
"Data recently received by the company shows that more people than expected who received the ASR Hip System experienced pain and other symptoms that led to a second hip replacement surgery, called a revision surgery. For this reason, DePuy Orthopaedics is voluntarily recalling its ASR™ XL Acetabular System and DePuy ASR™ Hip Resurfacing System. This recall means additional testing and treatment may be necessary to ensure the hip is functioning well. In some cases, patients may need additional surgery."
The Mass Tort Medical Device Team at Levin-Papantonio has a long history of handling defective orthopedic device cases such as Sulzer Hip and Knee Implants, Zimmer/Stryker Hip Implants, Calaxo Orthopedic Screw cases, and others. We have several attorneys at your disposal if you wish to discuss your Hip Implant surgery.
If you or a loved one have undergone total hip replacement surgery, please contact us for a free, no-obligation consultation to determine whether you have a claim for financial compensation against Depuy.
In The News
Article by guest commentator K.J. Bard
In recent news, the DePuy Orthopaedics division of Johnson & Johnson will be abandoning the manufacture and marketing of its metal-on-metal (MoM) hip replacements. In addition, DePuy will be discontinuing its Ceramic-on-Metal Acetabular Hip System. Both product lines will be unavailable after August of 2013; “related products” will be phased out over next year.
DePuy Bails from the Metal on Metal Hip Replacement Market by Withdrawing its Pinnacle Metal-on-Metal Line
By: Daniel Nigh
The most recent Chicago DePuy ASR trial has ended with a favorable verdict for the defense. In contrast with the recent $8.3 million California verdict for plaintiff Loren Kransky in California this March, the Chicago jury ruled against Carol Strum, whose attorneys asked for damages upwards of $5 million. Jurors heard the final arguments on April 15 and recessed for a day before returning to deliver the verdict the next evening.
"DePuy Orthopaedics Hips. Real Life Tested"
Those words still appear on a website maintained by the company (play the videos at the bottom or click on “read transcript”). Of course, these are about the newer Pinnacle hip device, not the ASR that so far has cost the company $8.3 million in a single lawsuit – with approximately 10,000 more cases lined up right behind it.
For a long time, the four manufacturers of hip and joint replacements that controlled 75% of the market were laughing all the way to the bank. These four companies – Stryker, Biomet, Du Puy and Zimmer – have been beneficiaries of a dysfunctional health care “system” that has no financial interest in healing patients.
In a recent news article, Gregory Demske, assistant inspector general for the U.S. Department of Health and Human Services, reported that the four largest manufacturers of hip replacements – all of which are facing legal action – paid “physician consultants” $800 million between 2002 and 2006. As defects in these designs became apparent and evidence surfaced to indicate that these companies were aware of the problems, these companies came under increasing scrutiny by the U.S. Department of Justice (DoJ).
LP attorney Ben Gordon quoted on the impact of the verdict for the plaintiff.
A California Jury returned an $8.3 million verdict against Johnson & Johnson and DePuy in the first trial regarding a plaintiff who was implanted with the recalled DePuy ASR hip implant. Over 10,000 plaintiffs across the United States have filed similar lawsuits against DePuy, and many of those plaintiffs required a revision to remove the recalled DePuy ASR hip implant. Often times, these plaintiffs had elevated levels of cobalt and chromium ions d
When Stryker Orthopaedics introduced its innovative Rejuvenate & ABG II Modular-Neck Hip Stems back in 2010, it was hailed as the greatest invention since the artificial hip implant. Two years later, the company issued a voluntary recall, and the product is now at the center of growing litigation.